Molecule of the year
At their core, biochemistry and molecular biology are all about how molecules interact.
Molecules catalyze reactions, form structural components and help carry important signals from one end of a system to the other. Proteins, nucleic acids, lipids, carbohydrates, metabolites and small molecules all play important roles in the vast network of life’s processes.
We invite you to nominate what you consider to be the most influential molecular discoveries and innovations for our inaugural "Molecule of the Year" contest.
Here’s how it works:
- From now until May 17, you can submit your nomination for the molecule of the year.
- From May 27 until June 14, all ASBMB members will have the chance to vote for the molecule they think is deserving of the title “Molecule of the Year.”
This is your chance to recognize the discoveries at the heart of groundbreaking advancements, whether it's a revolutionary drug, an important metabolite or an incredible enzyme. Nominate your choice for the Molecule of the Year and let's shine a spotlight on the molecules that make the world go round.
Questions? Contact Joanna Kotloski, membership director.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles
AI in the lab: The power of smarter questions
An assistant professor discusses AI's evolution from a buzzword to a trusted research partner. It helps streamline reviews, troubleshoot code, save time and spark ideas, but its success relies on combining AI with expertise and critical thinking.
Training AI to uncover novel antimicrobials
Antibiotic resistance kills millions, but César de la Fuente’s lab is fighting back. By pairing AI with human insight, researchers are uncovering hidden antimicrobial peptides across the tree of life with a 93% success rate against deadly pathogens.
AI-designed biomarker improves malaria diagnostics
Researchers from the University of Melbourne engineered Plasmodium vivax diagnostic protein with enhanced yield and stability while preserving antibody-binding, paving the way for more reliable malaria testing.
Matrix metalloproteinase inhibitor reduces cancer invasion
Scientists at the Mayo Clinic engineered a TIMP-1 protein variant that selectively inhibits MMP-9 and reduces invasion of triple-negative breast cancer cells, offering a promising tool for targeted cancer research.
Antibiotic sensor directly binds drug in resistant bacteria
Researchers at Drexel University uncover how the vancomycin-resistant bacterial sensor binds to the antibiotic, offering insights to guide inhibitor design that restores antibiotic effectiveness against hospital-acquired infections.
ApoA1 reduce atherosclerotic plaques via cell death pathway
Researchers show that ApoA1, a key HDL protein, helps reduce plaque and necrotic core formation in atherosclerosis by modulating Bim-driven macrophage death. The findings reveal new insights into how ApoA1 protects against heart disease.